A randomized, noninferiority study of recombinant human G-CSF/human serum albumin fusion (CG-10639) and pegfilgrastim in breast cancer patients receiving myelosuppressive therapy. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback